The CMT Research Foundation is pleased to announce that Bruce D. Carter, Ph.D., has joined the organization’s Scientific Advisory Board to help guide research strategy and funding to deliver treatments and cures for Charcot-Marie-Tooth (CMT) disease. Dr. Carter is a professor of biochemistry and the associate director of the Brain Institute at Vanderbilt University. His research focuses on the peripheral nervous system (PNS) and CMT, specifically the mechanisms by which neurotrophins regulate cell death in the developing PNS and the mechanisms underlying Schwann cell development and dysregulation, including in models of CMT.
Dr. Carter obtained his Ph.D. in biological chemistry from the University of Michigan. He did postdoctoral training at the Max Planck Institute in Munich, Germany, and the Cornell Medical School.
“I’m enthusiastic about being part of the CMT Research Foundation’s Scientific Advisory Board, not only because I have been studying Schwann cell biology for many years, but also because my nephew has a severe form of CMT. Efforts to find cures for CMT appeal to me intellectually, scientifically and personally in a poignant way.”
— Dr. Bruce Carter
To learn more about Dr. Carter and his research, visit his laboratory’s website.
Learn More about the CMT Research Foundation’s Scientific Advisory Board
The CMT Research Foundation’s Scientific Advisory Board consists of leading experts and scientists worldwide who dedicate their time and talents to guide the funding and delivery of CMT treatments and cures.
